Jian Yan
Impact in
- Virology top 1%
- HIV Research and Treatment
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 56
- Immunotherapy and Immune Responses 36
- Immune Cell Function and Interaction 16
- Co-authors
- David B. Weiner (74 shared papers)Amir Sada Khan (35 shared papers)Niranjan Y. Sardesai (41 shared papers)Matthew P. Morrow (27 shared papers)Ruxandra Draghia‐Akli (8 shared papers)Dominick J. Laddy (6 shared papers)Panyupa Pankhong (11 shared papers)Megan C. Wise (11 shared papers)
- Journals
- Molecular Therapy (14 papers)Vaccine (14 papers)Human Vaccines & Immunotherapeutics (8 papers)Retrovirology (5 papers)PLoS ONE (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Jian Yan
131 papers receiving 3.6k citations
Jian Yan's Hit Papers
Peers
Comparison fields: 5 of 118
- Virology 425
- Immunology 1.6k
- Biotechnology 391
- Hepatology 237
- Epidemiology 968
Countries citing papers authored by Jian Yan
This map shows the geographic impact of Jian Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Yan more than expected).
Fields of papers citing papers by Jian Yan
This network shows the impact of papers produced by Jian Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Yan. The network helps show where Jian Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jian Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 249 | |
| 2 | Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial Hit paper breakdown → | 2024 | 134 |
| 3 | 2017 | 130 | |
| 4 | 2009 | 130 | |
| 5 | 2008 | 122 | |
| 6 | 2008 | 120 | |
| 7 | 2014 | 113 | |
| 8 | 2005 | 111 | |
| 9 | 2009 | 106 | |
| 10 | 2007 | 102 | |
| 11 | 2008 | 75 | |
| 12 | 2007 | 62 | |
| 13 | 2014 | 60 | |
| 14 | 2008 | 56 | |
| 15 | 2013 | 56 | |
| 16 | 2010 | 55 | |
| 17 | 2010 | 53 | |
| 18 | 2013 | 52 | |
| 19 | 2013 | 52 | |
| 20 | 2007 | 50 |
About Jian Yan
Jian Yan is a scholar working on Immunology, Molecular Biology, Epidemiology, Virology and Infectious Diseases, having authored 132 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (16 papers), Hepatitis B Virus Studies (12 papers), Transgenic Plants and Applications (11 papers), Influenza Virus Research Studies (10 papers), Cervical Cancer and HPV Research (9 papers) and Infant Nutrition and Health (9 papers). The work is most often cited by research in Virology (425 citations), Immunology (1.6k citations), Biotechnology (391 citations), Hepatology (237 citations) and Epidemiology (968 citations). Jian Yan has collaborated with scholars based in United States, China and Canada. Frequent co-authors include David B. Weiner, Amir Sada Khan, Niranjan Y. Sardesai, Matthew P. Morrow, Ruxandra Draghia‐Akli, Dominick J. Laddy, Panyupa Pankhong, Megan C. Wise, Daniel O. Villarreal and Natasha Corbitt. Their work appears in journals such as Molecular Therapy, Vaccine, Human Vaccines & Immunotherapeutics, Retrovirology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.